Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation

Blood

Volumn 112, Issue 5, 2008, Pages 2160-2162

  Mochizuki, Kanako ^a   Sugimori, Chiharu ^a   Qi, Zhirong ^a   Lu, Xuzhang ^a   Takami, Akiyoshi ^a   Ishiyama, Ken ^a   Kondo, Yukio ^a   Yamazaki, Hirohito ^a   Okumura, Hirokazu ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DECAY ACCELERATING FACTOR; FLUDARABINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; TACROLIMUS; THYMOCYTE ANTIBODY; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN CLASS A PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW CELL; CASE REPORT; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; ENGRAFTMENT; EXON; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GRAFT FAILURE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORGAN DONOR; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ALLOTRANSPLANTATION; DONOR; GENETICS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; METABOLISM; MIDDLE AGED; MUTATION; TIME;

ANEMIA, APLASTIC; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 52649125582     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-141325     Document Type: Article

References (7)

1. Sugimori C, Chuhjo T, Feng X, et al. Minor population of CD55-GD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006:107:1308-1314.
2. Sugimori C, Yamazaki H, Feng X, et al. Roles of DRB1*1501 and DRB1*1502 in the pathogenesis of aplastic anemia. Exp Hematol. 2007;35:13-20.
3. Kai T, Shichishima T, Noji H, et al. Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2002;100:3812-3818.
4. Mortazavi Y, Merk B, Mcintosh J, et al. The spectrum of PIG-Agene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood. 2003;101: 2833-2841.
5. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989:17:2503-2516.
6. Dang RK, Anthony RS, Craig JI, Leonard RC, Parker AC. Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer. Mol Pathol. 2002;55:177-181.
7. Bai RK, Wong LJ. Detection and quantification of heteroplasmic mutant mitochondrial DNA by realtime amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem. 2004;50:996-1001.